BRAF and thyroid cancer: CGI indicated that (i) BRAF is a known oncogene driver in this cancer (Figure 4C); (ii) V600E is a common mutation seen in many types of cancers (including thyroid carcinoma; Figure 4D); and (iii) there are several approved targeted therapies for BRAF-mutant thyroid cancer (Figure 4E).